Diagnosed with primary adrenal insufficiency? search adrenoleukodystrophy-two brothers presented with similar phenotype
DOI:
https://doi.org/10.18203/2320-6012.ijrms20232118Keywords:
Addison’s disease, Primary adrenal insufficiency, ALDAbstract
X-linked adrenoleukodystrophy (X-ALD) is a genetic disease with a variety of phenotypic expression. This is the first case report of X-AMN/ALD in two brothers in Bangladesh confirmed by raised VLCFA. Our index patient of 19 years presented on 2014 with adrenal insufficiency, after one year developed progressive spastic paraparesis along with cognitive declination and behavioral abnormality. His only brother was clinically asymptomatic at presentation with Addison’s disease and extensor planter reflexes. After three years of follow up, index patient became bed bound with slurred speech, urinary urge incontinence and his brother developed spastic paraparesis with cognitive impairment. None had gonadal impairment. Follow up MRI after three years revealed lesion in brainstem in both along with atrophy of thoracic segment of spinal cord in index patient and cerebellum, internal capsule involvement in his brother. Both were of pure AMN variety but due to presence of cognitive impairment and behavioral abnormality they can be categorized as cerebral variety of AMN. On 2023, our index patient is still surviving with major functional disability and his brother died on 2019, 5 years of initial diagnosis.
References
Moser HW, Smith KD, Watkins PA, Powers J, Moser AB. X-linked adrenoleukodystrophy. In: Scriver CR, Beaudet AL, Sly WS, Valle D, eds. The Metabolic and Molecular Bases of Inherited Disease. New York, NY: McGraw Hill. 2001;3257-01.
Siemerling E, Creutzfeldt HG. Bronzekrankheit und sklerosierende Encephalomyelitis. Arch Psychiatr Nervkrankh. 1923;68:217-44.
Griffin JW, Goren E, Schaumburg H, Engel WK, Loriaux L. Adrenomyeloneuropathy: a probable variant of adrenoleukodystrophy.I. Clinical and endocrinologic aspects. Neurology. 1977;27:1107.
Mosser J, Douar AM, Sarde CO. Putative X-linked adrenoleukodystrophy gene shares unexpected homology with ABC transporters. Nature. 1993; 361:726-30.
Van Roermund CW, Visser WF, Ijlst L. The hu6w@1Q2 man peroxisomal ABC half transporter ALDP functions as a homodimer and accepts acyl-CoA esters. FASEB J. 2008;22:4201-8.
Ofman R, Dijkstra IM, van Roermund CW. The role of ELOVL1 in very long-chain fatty acid homeostasis and X-linked adrenoleukodystrophy. EMBO Mol Med. 2010,2:90-7.
Moser A, Jones RO, Hubbard WC. Newborn screening for X-linked adrenoleukodystrophy. Int J Neonatal Screen. 2016;2(4):1-5.
Engelen M, Van Ballegoij WJC, Mallack EJ. International recommendations for the diagnosis and management of patients with adrenoleukodystrophy: a consensus-based approach. Neurology. 2022;10.
Engelen M, Barbier M, Dijkstra IM. X-linked adrenoleukodystrophy in women: a cross-sectional cohort study. Brain. 2014;137(Pt 3):693-706.
Huffffnagel IC, Dijkgraaf MGW, Janssens GE. Disease progression in women with X-linked adrenoleukodystrophy is slow. Orphanet J Rare Dis. 2019;14(1):30.
Habekost CT, Schestatsky P, Torres VF. Neurological impairment among heterozygote women for X-linked Adrenoleukodystrophy: a case control study on a clinical, neurophysiological and biochemical characteristics. Orphanet J Rare Dis. 2014;9:6.
Dobyns WB, Filauro A, Tomson BN. Inheritance of most X-linked traits is not dominant or recessive, just X-linked. Am J Med Genet. 2004;129A:136-43.
Restuccia D, Di Lazzaro V, Valeriani M. Neurophysiological abnormalities in adrenoleukodystrophy carriers. Evidence of different degrees of central nervous system involvement. Brain. 1997;120:1139-48.
Horn MA, Nilsen KB, Jorum E, Mellgren SI, Tallaksen CM. Small nerve fifiber involvement is frequent in X-linked adrenoleukodystrophy. Neurology. 2014;82(19):1678-83.
Schmidt S, Traber F, Block W. Phenotype assignment in symptomatic female carriers of X-linked adrenoleukodystrophy. J Neurol. 2001;248(1):36-44.
Mondol MBA, Siddiqui MMR, Wahab L. Adrenoleukodystrophy: A Rare Case Report. J Bangladesh College of Physicians and Surgeons. 2010;28(3):189-92.
Kemp S, Huffffnagel IC, Linthorst GE, Wanders RJ, Engelen M. Adrenoleukodystrophy-neuroendocrine pathogenesis and redefifinition of natural history. Nat Rev Endocrinol. 2016;12(10):606-615.
Petryk A, Polgreen LE, Chahla S. No evidence for the reversal of adrenal failure after hematopoietic cell transplantation in X-linked adrenoleukodystrophy. Bone Marrow Transplant. 2012;47:1377-8.
Newborn-screening.html. Available at: https://www.aldalliance.org/newbornscreening.html. Accessed on 11 May 2023.
Loeber JG, Platis D, Zetterstro¨m RH. Neonatal screening in Europe revisited: an ISNS perspective on the current state and developments since 2010. Int J Neonatal Screen. 2021;7:15.
Brooke AM, Monson JP. Addison’s disease. Medicine. 2009;37(8):416-9.
Bhatia E, Jain SK, Gupta RK, Pandey R. Tuberculous Addison’s disease: lack of normalization of adrenocortical function after anti-tuberculous chemotherapy. Clin Endocrinol. (Oxf). 1998;48(3):355-9.
Guo YK, Yang ZG, Li Y. Addison’s disease due to adrenal tuberculosis: contrast-enhanced features and clinical duration correlation. Eur J Radiol. 2007;62(1):126-31.
Laureti S, Casucci G, Santeusanio F, Angeletti G, Aubourg P, Brunetti P. X-linked adrenoleukodystrophy is a frequent cause of idiopathic Addison's disease in young adult male patients. J Clin Endocr Metab. 1996;81:470-74.
Burtman E, Regelmann MO. Endocrine dysfunction in X-linked adrenoleukodystrophy. Endocrinol Metab Clin North Am. 2016;45:295-309.
Dubey P, Raymond GV, Moser AB. Adrenal insufficiency in asymptomatic adrenoleukodystrophy patients identifified by very long-chain fatty acid screening. J Pediatr. 2005;146:528-32.
Regelmann MO, Kamboj MK, Miller BS. Adrenoleukodystrophy: guidance for adrenal surveillance in males identifified by newborn screen. J Clin Endocrinol Metab. 2018;103:4324-31.
Sadeghi-Nejad A, Senior B. Adrenomyeloneuropathy presenting as Addison’s disease in childhood. N Engl J Med. 1990;322:13-6.
Regelmann MO, Kamboj MK, Miller BS. Adrenoleukodystrophy: guidance for adrenal surveillance in males identifified by newborn screen. J Clin Endocrinol Metab. 2018;103:4324-31.
Moser HW, Moser AB, Steinberg SJ. X-linked adrenoleukodystrophy. Gene Reviews. www.genetests.org. Accessed on 06 February 2023.
Percy AK, Rutledge SL. Adrenoleukodystrophy and related disorders. Ment Retard Dev Disabil Res Rev. 2001;7:179.
Turk BR, Theda C, Fatemi A, Moser AB. X-linked adrenoleukodystrophy: Pathology, pathophysiology, diagnostic testing, newborn screening and therapies. Int J Dev Neurosci. 2020; 80:52-72.
Moser HW, Moser AB, Naidu S, Bergin A. Clinical aspects of adrenoleukodystrophy and adrenomyeloneuropathy. Dev Neurosci. 1991;13(4-5):254-61.
Girard S, Bruckert E, Turpin G. Endocrine disease in adrenoleukodystrophy. Ann Med Interne. 2001;152(1):15-26.
Powers JM, Schaumburg HH. The testis in adreno-leukodystrophy. Am J Pathol. 1981;102:90-8.
Van Geel BM, Bezman L, Loes DJ, Moser HW, Raymond GV. Evolution of phenotypes in adult male patients with X-linked adrenoleukodystrophy. Ann Neurol. 2001;49:186-94.
De Beer M, Engelen M, Van Geel BM. Frequent occurrence of cerebral demyelination in adrenomyeloneuropathy. Neurology. 2014; 83:2227-31.
Zhu J, Eichler F, Biffi A. The Changing Face of Adrenoleukodystrophy. Endocr Rev. 2020;41(4):577-93.
JM, DeCiero DP, Ito M, Moser AB, Moser HW. Adrenomyeloneuropathy: a neuropathologic review featuring its noninflammatory myelopathy. J Neuropathol Exp Neurol. 2000;59:89-102.
Dubey P, Fatemi A, Huang H. Diffusion tensor-based imaging reveals occult abnormalities in adrenomyeloneuropathy. Ann Neurol. 2005;58:758-66.
Fatemi A, Smith SA, Dubey P. Magnetization transfer MRI demonstrates spinal cord abnormalities in adrenomyeloneuropathy. Neurology. 2005;64:1739-45.
Smith SA, Golay X, Fatemi A. Quantitative magnetization transfer characteristics of the human cervical spinal cord in vivo: application to adrenomyeloneuropathy. Magn Reson Med. 2009;61:22-7.
Van Geel BM, Koelman JH, Barth PG, Ongerboer de Visser BW. Peripheral nerve abnormalities in adrenomyeloneuropathy: a clinical andelectrodiagnostic study. Neurology. 1996;46:112-8.
Konig A, Happle R, Tchitcherina E. An X-linked gene involved in androgenetic alopecia: a lesson to be learned from adrenoleukodystrophy. Dermatology. 2000;200(3):213-8.
Harris-Jones JN, Nixon PG. Familial Addison's disease with spastic paraplegia. J Clin Endocrinol Metab.1955;15:739-44.
Moser HW, Raymond GV, Dubey P. Adrenoleukodystrophy, New Approaches to a Neurodegenerative Disease JAMA. 2005;294:3131-4.
Moser HW, Loes DJ, Melhem ER. X-Linked adrenoleukodystrophy: overview and prognosis as a function of age and brain magnetic resonance imaging abnormality. A study involving 372 patients. Neuropediatrics. 2000;31:227-39.